US Dermatology OTC Medications Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US Dermatology OTC Medications Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US Dermatology OTC Medications Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US Dermatology OTC Medications Market Regional Analysis

6.2 US Dermatology OTC Medications Market Revenue 2018-2028 (US$ Million)

6.3 US Dermatology OTC Medications Market Forecast Analysis

7. US Dermatology OTC Medications Market Analysis – by Product Type

7.1 Tablets and Capsules

7.1.1 Overview
7.1.2 Tablets and Capsules: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.2 Oils

7.2.1 Overview
7.2.2 Oils: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.3 Gels

7.3.1 Overview
7.3.2 Gels: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.4 Creams and Ointments

7.4.1 Overview
7.4.2 Creams and Ointments: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8. US Dermatology OTC Medications Market Analysis – by Indication

8.1 Dermatitis

8.1.1 Overview
8.1.2 Dermatitis: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.2 Acne

8.2.1 Overview
8.2.2 Acne: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.3 Psoriasis

8.3.1 Overview
8.3.2 Psoriasis: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.4 Skin Bleaching

8.4.1 Overview
8.4.2 Skin Bleaching: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.5 Anti-Fungal

8.5.1 Overview
8.5.2 Anti-Fungal: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

8.6 Wart Remover

8.6.1 Overview
8.6.2 Wart Remover: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

9. US Dermatology OTC Medications Market Analysis – by Route of Administration

9.1 Topical

9.1.1 Overview
9.1.2 Topical: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

9.2 Oral

9.2.1 Overview
9.2.2 Oral: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

10. US Dermatology OTC Medications Market Analysis – by Distribution Channel

10.1 Online Distribution

10.1.1 Overview
10.1.2 Online Distribution: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

10.2 Hospital and Retail Pharmacies

10.2.1 Overview
10.2.2 Hospital and Retail Pharmacies: US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

10.3 Super and Hyper Markets

10.3.1 Overview
10.3.2 Super and Hyper Markets : US Dermatology OTC Medications Market – Revenue and Forecast, 2018-2028 (US$ Million)

11. US Dermatology OTC Medications Market – United States Analysis

11.1 Overview

11.2 United States

11.2.1 US Dermatology OTC Medications Market Breakdown, by Key Country, 2021 and 2028 (%)
11.2.1.1 US Dermatology OTC Medications Market – Revenue and Forecast Analysis – by Country
11.2.1.1 United States : US Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 United States : US Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.1.2 United States : US Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.1.3 United States : US Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.1.4 United States : US Dermatology OTC Medications Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bausch Health Companies Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Perrigo Company Plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Bayer AG

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Viatris Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Johnson and Johnson Services, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 LEO Pharma A/S

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 GlaxoSmithKline Plc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Galderma

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Dr. Reddy's Laboratories

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Acella Pharmaceuticals, LLC

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

US Dermatology OTC Medications Market